| 臺大學術典藏 |
2021-07-21T23:21:16Z |
Functional Status After Pulmonary Rehabilitation as a Predictor of Weaning Success and Survival in Patients Requiring Prolonged Mechanical Ventilation
|
LI-TA KENG; SHENG-KAI LIANG; Tseng, Chi Ping; Wen, Yueh Feng; PING-HSIEN TSOU; CHIA-HAO CHANG; LIH-YU CHANG; KAI-LUN YU; MENG-RUI LEE; JEN-CHANG KO |
| 臺大學術典藏 |
2021-07-20T07:54:39Z |
Evaluating pleural ADA, ADA2, IFN-γ and IGRA for diagnosing tuberculous pleurisy
|
LIH-YU CHANG; LI-TA KENG; Chin-Chung Shu; Jason Yao-Ping Chen; SHENG-KAI LIANG; Ching-Kai Lin; LIH-YU CHANG; CHIA-HAO CHANG; Jann-Yuan Wang; Chong-Jen Yu; Li-Na Lee |
| 臺大學術典藏 |
2021-07-14T07:15:22Z |
Functional Status After Pulmonary Rehabilitation as a Predictor of Weaning Success and Survival in Patients Requiring Prolonged Mechanical Ventilation
|
JEN-CHUNG KO; LI-TA KENG; SHENG-KAI LIANG; PING-HSIEN TSOU; CHIA-HAO CHANG; LIH-YU CHANG; KAI-LUN YU; MENG-RUI LEE; Tseng, Chi-Ping ; Wen, Yueh-Feng |
| 臺大學術典藏 |
2021-07-14T07:15:21Z |
Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancer
|
JEN-CHUNG KO; PING-HSIEN TSOU; CHIEN-JEN CHANG; SHENG-KAI LIANG; CHIA-HAO CHANG; LIH-YU CHANG; KAI-LUN YU; LI-TA KENG; MENG-RUI LEE; Zong-Lin Lin ; Yu-Chiang Pan ; Hui-Chen Yang ; Yueh-Feng Wen ; Chia-Jung Liu ; Guan-Hua Huang and Yaw-Kuen Li |
| 臺大學術典藏 |
2021-04-21T23:30:28Z |
Exploring volatile organic compounds in breath for high-accuracy prediction of lung cancer
|
PING-HSIEN TSOU; Lin, Zong Lin; Pan, Yu Chiang; Yang, Hui Chen; CHIEN-JEN CHANG; SHENG-KAI LIANG; Wen, Yueh Feng; CHIA-HAO CHANG; LIH-YU CHANG; KAI-LUN YU; Liu, Chia Jung; LI-TA KENG; MENG-RUI LEE; JEN-CHANG KO; Huang, Guan Hua; Li, Yaw Kuen |
| 臺大學術典藏 |
2021-03-12T07:59:00Z |
Ultrasound-Guided Needle Electromyography for Assessing Diaphragmatic Myoclonus
|
Kai Hsiang Stanley Chen; LI-TA KENG; Yu-Ting Kuo; Yi-Cheng Tai; Robert Chen |
| 臺大學術典藏 |
2021-03-11T08:34:21Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; Min-Shu Hsieh; MENG-RUI LEE; LI-TA KENG; JEN-CHANG KO; Jin-Yuan Shih |
| 臺大學術典藏 |
2021-03-11T08:34:20Z |
Cementing an unwanted relationship
|
Chang C.-H.;Keng L.-T.;Jen-Chang Ko; CHIA-HAO CHANG; LI-TA KENG; JEN-CHANG KO |
| 臺大學術典藏 |
2021-03-11T08:34:15Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Wen Y.-F.; MENG-RUI LEE; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-03-09T08:07:35Z |
Pulmonary granulomas: Give it a whorl
|
WEI-YUNG LO; SHENG-KAI LIANG; LI-TA KENG; Hsien-Neng Huang , Huan-Jang Ko |
| 臺大學術典藏 |
2021-02-08T08:05:08Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Jen-Chung Ko;Sheng-Kai Liang;Li-Ta Keng;Chia-Hao Chang;Yueh-Feng Wen ; Meng-Rui Lee ; Ching-Yao Yang ; Jann-Yuan Wang ; Jin-Yuan Shih ; Chong-Jen Yu; JEN-CHUNG KO; SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Yueh-Feng Wen ; Meng-Rui Lee ; Ching-Yao Yang ; Jann-Yuan Wang ; Jin-Yuan Shih ; Chong-Jen Yu |
| 臺大學術典藏 |
2021-02-02T09:21:39Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Wen, Yueh Feng; MENG-RUI LEE; Yang, Ching Yao; JANN-YUAN WANG; JEN-CHUNG KO; JIN-YUAN SHIH; CHONG-JEN YU |
| 臺大學術典藏 |
2021-01-19T12:08:48Z |
Pulmonary granulomas: Give it a whorl
|
LI-TA KENG; WEI-YUNG LO; Hsien-Neng Huang; Ko, Huan Jang; SHENG-KAI LIANG |
| 臺大學術典藏 |
2021-01-08T02:56:51Z |
Risk factors for Mycobacterium chelonae-abscessus pulmonary disease persistence and deterioration
|
Pan-Chyr Yang; Chong-Jen Yu; Li-Na Lee; MENG-RUI LEE; LI-TA KENG; Chin-Chung Shu; Shih-Wei Lee; Chih-Hsin Lee; Jann-Yuan Wang |
| 臺大學術典藏 |
2021-01-08T02:56:50Z |
Diagnostic role of inflammatory and anti-inflammatory cytokines and effector molecules of cytotoxic T lymphocytes in tuberculous pleural effusion
|
Shu C.-C.;Wang J.-Y.;Hsu C.-L.;Li-Ta Keng;Tsui K.;Lin J.-F.;Lai H.-C.;Yu C.-J.;Lee L.-N.;Luh K.-T.; Chin-Chung Shu; Jann-Yuan Wang; Chia-Lin Hsu; LI-TA KENG; Kochung Tsui; Jeng-Feng Lin; Hsin-Chih Lai; Chong-Jen Yu; Li-Na Lee; Kwen-Tay Luh |
| 臺大學術典藏 |
2021-01-08T02:56:50Z |
Gas-forming liver abscess with pneumocardia
|
Li-Ta Keng;Fu Y.-H.;Lin Y.-H.; LI-TA KENG; Yang-Hsien Fu; Yen-Huai Lin |
| 臺大學術典藏 |
2021-01-08T02:56:50Z |
Evaluating pleural ADA, ADA2, IFN-γ and IGRA for diagnosing tuberculous pleurisy
|
LI-TA KENG; Shu C.-C.; Chen J.Y.P.; Liang S.-K.; Lin C.-K.; Chang L.-Y.; Chang C.-H.; Wang J.-Y.; Yu C.-J.; Lee L.-N. |
| 臺大學術典藏 |
2021-01-08T02:56:49Z |
Posterior consolidation: An important clue for differentiating ARDS from cardiogenic pulmonary edema: To the editor
|
Li-Ta Keng; LI-TA KENG |
| 臺大學術典藏 |
2021-01-08T02:56:49Z |
Prospective evaluation of procalcitonin, soluble triggering receptor expressed on myeloid cells-1 and c-reactive protein in febrile patients with autoimmune diseases
|
Lin C.-H.;Hsieh S.-C.;Li-Ta Keng;Lee H.-S.;Chang H.-T.;Liao W.-Y.;Ho C.-C.;Yu C.-J.; Chou-Han Lin; Song-Chou Hsieh; LI-TA KENG; Ho-Sheng Lee; Hou-Tai Chang; Wei-Yu Liao; Chao-Chi Ho; Chong-Jen Yu |
| 臺大學術典藏 |
2021-01-08T02:56:49Z |
Carotid artery calcification
|
Li-Ta Keng; Lin Y.-H.;Lee C.-P.; LI-TA KENG; Lin Y.-H.; Lee C.-P. |
| 臺大學術典藏 |
2021-01-08T02:56:49Z |
Upper lobe or upper division bronchus
|
Li-Ta Keng; LI-TA KENG |
| 臺大學術典藏 |
2021-01-08T02:56:48Z |
Complications of Central Venous Catheterization
|
Li-Ta Keng; LI-TA KENG |
| 臺大學術典藏 |
2021-01-08T02:56:48Z |
Unusual ileus due to calcium polystyrene sulfonate
|
Li-Ta Keng;Tsou P.-H.; LI-TA KENG; PING-HSIEN TSOU |
| 臺大學術典藏 |
2021-01-08T02:56:48Z |
Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment
|
Li-Ta Keng;Lin M.-W.;Huang H.-N.;Chung K.-P.; LI-TA KENG; Lin M.-W.; Huang H.-N.; Chung K.-P. |
| 臺大學術典藏 |
2021-01-08T02:56:48Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Li-Ta Keng;Ko J.-C.;Shih J.-Y.; Liang S.-K.; Hsieh M.-S.; Lee M.-R.; LI-TA KENG; Ko J.-C.; Shih J.-Y. |
